Publications by authors named "J W Mapletoft"

Article Synopsis
  • Cigarette smoke exposure decreases the ability of the upper respiratory tract to produce protective antibodies, specifically IgA, which are crucial for immune defense.
  • Evidence from a murine model indicates that this exposure reduces the number of antibody-secreting cells and their effectiveness in responding to antigens.
  • Mechanistically, cigarette smoke impairs processes necessary for antibody production and transport in the nasal mucosa, highlighting its immunosuppressive effects.
View Article and Find Full Text PDF

Conventional drug sensitivity assays used to screen prospective anti-cancer agents for cytotoxicity monitor biological processes associated with active growth and proliferation, used as proxies of cell viability. However, these assays are unable to distinguish between growth-arrested (but otherwise viable) cells and non-viable/dead cells. As a result, compounds selected based on the results of these assays may only be cytostatic, halting or slowing tumour progression temporarily, without tumour eradication.

View Article and Find Full Text PDF

Most currently available vaccines, particularly live vaccines, require the cold chain, as vaccine efficacy can be significantly hampered if they are not stored in a temperature range of 2-8 °C at all times. This necessity places a tremendous financial and logistical burden on vaccination programs, particularly in the developing world. The development of thermally stable vaccines can greatly alleviate this problem and, in turn, increase vaccine accessibility worldwide.

View Article and Find Full Text PDF

Chronic wasting disease (CWD) is a fatal prion disease affecting multiple cervid species. Effective management tools for this disease, particularly in free-ranging populations, are currently limited. We evaluated a novel CWD vaccine in elk (Cervus canadensis) naturally exposed to CWD through a prion-contaminated environment.

View Article and Find Full Text PDF

Vaccination against the seasonal influenza virus is the best way to prevent infection. Nevertheless, vaccine efficacy remains far from optimal especially in high-risk populations such as the elderly. Recent technological advancements have facilitated rapid and precise identification of the B and T cell epitopes that are targets for protective responses.

View Article and Find Full Text PDF